Skip to content

Clinical trials

Observational Nasopharyngeal Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nasopharyngeal Carcinoma Phase: Observational Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20053
20062
20071
20081
20104
20112
20125
20131
20143
20155
20165
20176
20185
20195
20207
20218
20228
202310
202415
20258
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status42
Completed28
Recruiting24
Not yet recruiting7
Active, not recruiting7
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University25
Taichung Veterans General Hospital7
Fujian Cancer Hospital5
Nanfang Hospital, Southern Medical University5
National Taiwan University Hospital4
The University of Hong Kong4
Zhejiang Cancer Hospital4
Jiangxi Provincial Cancer Hospital3
National Cancer Institute (NCI)3
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nasopharyngeal Carcinoma111
Epstein-Barr Virus Infections9
Neoplasms7
Nasopharyngeal Neoplasms5
Head and Neck Neoplasms4
Laryngeal Neoplasms2
Malnutrition2
Melanoma2
Mesothelioma2
Neoplasms, Unknown Primary2

Trials

Showing 51 to 75 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.